We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+2.73%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$7.58B
AUM Growth
+$139M
Cap. Flow
+$177M
Cap. Flow %
2.33%
Top 10 Hldgs %
25.49%
Holding
165
New
14
Increased
52
Reduced
27
Closed
13

Top Buys

Rank Stock Value
1
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$63.7M
2
FIVN icon
FIVE9
FIVN
+$52.6M
3
XMTR icon
Xometry
XMTR
+$50.4M
4
GLBE icon
Global E Online
GLBE
+$32.3M
5
FVRR icon
Fiverr
FVRR
+$31.6M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$83.1M
2
TRIL
Trillium Therapeutics Inc.
TRIL
+$50M
3
CLDX icon
Celldex Therapeutics
CLDX
+$46M
4
BBIO icon
BridgeBio Pharma
BBIO
+$43.4M
5
RNG icon
RingCentral
RNG
+$39.4M

Sector Composition

Rank Sector Weight
1 Healthcare 34.36%
2 Technology 30.11%
3 Industrials 12.97%
4 Consumer Discretionary 7.19%
5 Communication Services 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16.5B
$279M 3.68%
1,748,648
+50,000
+3% +$6.84M
FIVN icon
2
FIVE9
FIVN
$2.12B
$235M 3.09%
1,469,015
+288,500
+24% +$52.6M
CRWD icon
3
CrowdStrike
CRWD
$189B
$195M 2.57%
3,173,140
-392,000
-11% -$25.3M
DT icon
4
Dynatrace
DT
$12.8B
$194M 2.56%
2,737,908
+7,600
+0.3% +$498K
TTD icon
5
Trade Desk
TTD
$8.59B
$194M 2.56%
2,756,430
– –
BHVN
6
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$184M 2.43%
1,325,000
-665,797
-33% -$83.1M
IDXX icon
7
Idexx Laboratories
IDXX
$44.1B
$175M 2.31%
281,700
+41,700
+17% +$28M
MTD icon
8
Mettler-Toledo International
MTD
$27.9B
$174M 2.3%
126,500
+14,500
+13% +$21.8M
HUBS icon
9
HubSpot
HUBS
$11.9B
$161M 2.12%
237,937
– –
EXAS
10
DELISTED
Exact Sciences
EXAS
$142M 1.88%
1,490,000
-250,000
-14% -$26.4M
ROP icon
11
Roper Technologies
ROP
$38.5B
$139M 1.84%
312,400
– –
GTM
12
ZoomInfo Technologies
GTM
$978M
$130M 1.71%
2,120,101
+177,750
+9% +$10.6M
GNRC icon
13
Generac Holdings
GNRC
$11.3B
$129M 1.7%
315,800
– –
ASML icon
14
ASML
ASML
$634B
$128M 1.69%
172,000
– –
FVRR icon
15
Fiverr
FVRR
$330M
$127M 1.68%
696,962
+157,000
+29% +$31.6M
ODFL icon
16
Old Dominion Freight Line
ODFL
$44.2B
$127M 1.68%
890,400
+6,000
+0.7% +$833K
TWLO icon
17
Twilio
TWLO
$29B
$126M 1.66%
393,490
– –
SPT icon
18
Sprout Social
SPT
$509M
$121M 1.6%
995,919
-16,001
-2% -$1.74M
LRCX icon
19
Lam Research
LRCX
$372B
$116M 1.53%
2,044,460
– –
XIFR
20
XPLR Infrastructure LP
XIFR
$1.12B
$115M 1.52%
1,532,000
+204,900
+15% +$16M
TT icon
21
Trane Technologies
TT
$97.3B
$110M 1.46%
640,000
+6,500
+1% +$1.25M
CTAS icon
22
Cintas
CTAS
$82.7B
$110M 1.45%
1,158,400
– –
POOL icon
23
Pool Corp
POOL
$6.95B
$109M 1.44%
251,800
– –
ZYME icon
24
Zymeworks
ZYME
$1.67B
$108M 1.43%
3,729,189
+528,461
+17% +$17.6M
LOW icon
25
Lowe's Companies
LOW
$118B
$103M 1.36%
507,600
+8,200
+2% +$1.63M
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Eventide Asset Management held 165 positions worth $7.58B, up 1.9% from $7.44B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management's Q3 2021 filing shows 14 new, 52 increased, 27 reduced and 13 closed positions. Its largest new stake was DICE Therapeutics, Inc. Common Stock: 1,871,612 shares worth $59.2M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $83.1M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q3 2021 buy was DICE Therapeutics, Inc. Common Stock: 1,871,612 shares worth $59.2M.
  • Eventide Asset Management added most to FIVE9 in Q3 2021, an estimated $52.6M increase.
  • Eventide Asset Management's biggest Q3 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $83.1M.
  • Eventide Asset Management fully exited BridgeBio Pharma in Q3 2021, selling an estimated $43.4M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $7.58B portfolio in Q3 2021.
  • Eventide Asset Management opened 14 new positions and closed 13 in Q3 2021.
  • Eventide Asset Management's portfolio value rose 1.9% quarter-over-quarter to $7.58B.

Based on Eventide Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.